Sana Biotechnology (SANA) Interest & Investment Income (2020 - 2026)

Sana Biotechnology has reported Interest & Investment Income for 7 years, with the latest figure at -$30000.0 in Q1 2026.

• Quarterly Interest & Investment Income fell 114.29% year-over-year to -$30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2000.0 (down 113.33% YoY) and the FY2025 annual result came in at $14000.0, down 81.08% from the prior year.
• Interest & Investment Income declined to -$30000.0 in Q1 2026 per SANA's latest filing, from $7000.0 in the prior quarter.
• Over five years, Interest & Investment Income peaked at $2.2 million in Q1 2023 and troughed at -$3.8 million in Q1 2022.
• A 5-year average of $85250.0 and a median of $14000.0 in 2025 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2022 and 2023: Interest & Investment Income plunged 14738.46% in 2022, then surged 1089.55% in 2023.
• Over 5 years, Interest & Investment Income stood at $2.1 million in 2022, then plunged by 93.2% to $142000.0 in 2023, then plunged by 128.17% to -$40000.0 in 2024, then surged by 117.5% to $7000.0 in 2025, then sank by 528.57% to -$30000.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered -$30000.0, $7000.0, and $21000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.